RP 1.25 > (Ramipril 1.25 mg)
This pill with imprint "RP 1.25 >" is White & Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by Cobalt Laboratories Inc.
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure; cardiovascular risk reduction (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Ramipril
- Imprint:
- RP 1.25 >
- Strength:
- 1.25 mg
- Color:
- White & Yellow
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cobalt Laboratories Inc
- Inactive Ingredients:
- corn starch
gelatin
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
Imprint Code FAQ's
Other Labelers / Repackagers:| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0294 | Amerisource Health Services |
| 54868-5896 | Physicians Total Care Inc (repackager) |
More about ramipril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 53 Reviews – Add your own review/rating
- Drug class: Angiotensin Converting Enzyme Inhibitors
Consumer resources
Other brands: Altace
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
